Clarivate for Life Sciences & Healthcare

Heading to BIO in San Diego? Meet our team at #BIO2026 to discover how the right insights can accelerate partnerships, strengthen pipeline decisions, and help you move forward with clarity and confidence. If you're looking to: ✅ Identify the right partners earlier ✅ De-risk decisions with predictive insights ✅Stay ahead of competitors ✅ Understand the market in real time ✅ Move faster with limited resources Get prepared before you arrive. Access to BIO event prep kit with key insights and data you can use to get ready for meetings and conversations: https://ow.ly/lyRv50Z9PGZ Let’s connect during BIO. Book a meeting with Mark Rubio: https://ow.ly/QSuS50Z9PGY #BIOConvention #BIO2026 #Biotech #LifeSciences #BusinessDevelopment

What if finding complex drug safety insights felt as simple as asking a question? Starting today, it can. We’re excited to launch the new OFF-X AI Safety Assistant — designed to help researchers and safety teams uncover trusted drug and target safety insights faster through a conversational AI experience. Built on expert-curated OFF-X intelligence, the Assistant helps users: ✔ Ask complex safety questions in natural language ✔ Get instant, evidence-based answers ✔ Explore linked supporting sources ✔ Surface high-value safety insights faster ✔ Keep context with chat history and streamlined workflows From adverse event comparisons to preclinical safety findings, the OFF-X AI Safety Assistant helps transform how teams interact with translational safety intelligence. Watch the video to see it in action. Learn more: https://ow.ly/hVUS50Z9o5Y #DrugSafety #AI #Toxicology

Artificial intelligence is transforming life sciences, but according to Henry Levy, President of Clarivate Life Sciences & Healthcare, the real shift isn't just about adopting AI, it's about rethinking how decisions are made. In this executive interview with Fierce Biotech, Henry discusses: 👉 Why AI alone isn't enough 👉 The importance of trusted, decision-grade data 👉 How organizations can combine AI with human expertise 👉 What it takes to make faster, more confident strategic decisions Watch the interview: https://ow.ly/amWY50Z9sz7 Interested in how Clarivate is bringing trusted AI to life sciences workflows? Learn more here: https://ow.ly/T2vu50Z9sSF #AI #Biotech #LifeSciences #DecisionIntelligence #Pharma #ArtificialIntelligence

ADC development requires navigating complex trade‑offs across targets, linkers, payloads, and competitive pipelines. Watch how Cortellis Drug Discovery AI Assistant helps: 👉Identify organizations developing preclinical ADCs for specific targets 👉Build tables comparing linker and payload strategies 👉List ADCs using specific linker chemistries A structured way to explore ADC design precedent and pipeline activity using trusted drug development intelligence. Book a demo now: https://ow.ly/Gbbs50Z9m6S #ADCs #DrugDiscovery #OncologyResearch #LifeSciences

Biomedical research generates vast amounts of data, but turning that data into meaningful decisions remains a challenge. In this webinar, Clarivate experts - Matthew Wampole, Director, Solution Consulting, Gaia Ceddia, Manager, Discovery and Translational Science and Anton Kichev, PhD, Senior Consultant, Discovery and Translational Science - will showcase a biomedical knowledge graph with 2.4 million nodes and 10 million relationships, demonstrating how AI-driven exploration can reveal connections across genes, diseases, drugs, pathways, biomarkers, and clinical evidence. Register: https://ow.ly/MMZl50Z9mlH #KnowledgeGraphs #LifeSciences #Bioinformatics #AIinHealthcare

The shift toward outpatient and ASC settings continues to reshape how and where procedures are delivered — opening new opportunities for some therapy areas while increasing operational and reimbursement pressure for others. April Chan-Tsui, Director, Product Operations, Medtech, Clarivate, outlines how recent CMS updates, expanding ASC‑eligible procedures and long‑standing site‑of‑care migration are influencing provider economics, device utilization and commercial strategy. Explore this trend and beyond in our recent Medtech Trends to Watch 2026 report: https://ow.ly/ylT550Z69ZW For ongoing intelligence, market insights and expert analysis throughout the year, explore our Medtech Insights hub: https://ow.ly/942b50Z6a67 #Medtech #MedtechTrendsToWatch2026 #Outpatient #HealthcareDelivery

Ovarian cancer treatment is rapidly shifting toward biomarker-driven therapies, but access is increasingly shaped by payer coverage decisions. Fingertip coverage trends in ovarian cancer highlight a clear preference for therapies with narrowly defined patient populations and transparent prior authorization pathways. PARP inhibitors such as Lynparza and Zejula continue to maintain preferred formulary positioning, while biosimilars like Zirabev have largely displaced branded bevacizumab in many plans. Stay ahead of shifting coverage trends and emerging therapies across key cancers here:https://ow.ly/i1VU50Z8Thk #OvarianCancer #Oncology #MarketAccess #HealthcareInsights

Join us at Drug Discovery Europe 2026, where 1,000+ senior scientists, R&D leaders, and innovators will come together to discuss how AI, advanced biology, and data-driven intelligence are transforming the path from target to candidate.     🗓 Save the date: 15–16 June 2026 📍 Where: Berlin, Germany 🎮 AI & Digitalization Zone | F1 VR Station   Meet our team - Sonia Giral López, MD PhD, Dino Baum, Cecilia Coimbra Klein, PhD and Carolyn Finch - on site to explore how Clarivate’s trusted insights, data, and advanced analytics help accelerate discovery, support smarter decision‑making, and drive impactful R&D outcomes.   As we race for the top spot on the F1 VR track, let's also explore how we can help drug discovery move faster—from idea to impact.   Set up a meeting in advance or drop by the F1 VR Station for a drive and a chat.   Book a meeting: https://lnkd.in/g7hhs2vU   #OGDiscovery #DDEU26 #AI #Clarivate | Discovery & Development by Oxford Global

Choosing the right Medicare coverage can be complex, particularly as beneficiaries weigh differences in cost, coverage, provider access, and flexibility. In a recent U.S. News & World Report feature Dee Chaudhary, BA MBA Chaudhary, Principal, Commercial Strategy Consulting at Clarivate, shares insights on the key distinctions between Medicare Advantage and Medicare Cost Plans, helping consumers better understand how these options compare and what factors may influence plan selection. As the healthcare landscape continues to evolve, access to clear, evidence-based information remains critical for informed decision-making. Read the article to learn more: https://lnkd.in/e782Pw84 #Medicare #HealthcarePolicy #HealthInsurance #HealthcareAccess #Clarivate

Knowledge graphs are transforming how biomedical researchers connect complex data and uncover actionable insights. Join - Matthew Wampole, Director, Solution Consulting , Gaia Ceddia, Manager, Discovery and Translational Science and Anton Kichev, PhD, Senior Consultant, Discovery and Translational Science - on June 18 for a webinar exploring how AI-powered knowledge graphs can accelerate target discovery, mechanism of action studies, safety assessment, and translational research. Discover how natural language querying is making advanced biomedical analytics accessible to both scientists and non-experts. Register: https://ow.ly/fK1C50Z7BT1 #KnowledgeGraphs #BiomedicalResearch #ArtificialIntelligence #DrugDiscovery #Webinar